2,525 Shares in Markel Group Inc. $MKL Purchased by IFM Investors Pty Ltd

IFM Investors Pty Ltd purchased a new stake in shares of Markel Group Inc. (NYSE:MKL) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 2,525 shares of the insurance provider’s stock, valued at approximately $4,833,000.

A number of other large investors have also recently modified their holdings of MKL. Davis Selected Advisers boosted its position in Markel Group by 11.1% during the 4th quarter. Davis Selected Advisers now owns 415,160 shares of the insurance provider’s stock valued at $892,496,000 after acquiring an additional 41,632 shares in the last quarter. Select Equity Group L.P. grew its holdings in shares of Markel Group by 75.9% during the 2nd quarter. Select Equity Group L.P. now owns 336,369 shares of the insurance provider’s stock worth $671,850,000 after acquiring an additional 145,146 shares during the period. State Street Corp raised its position in shares of Markel Group by 2.1% in the 3rd quarter. State Street Corp now owns 304,400 shares of the insurance provider’s stock worth $581,818,000 after acquiring an additional 6,160 shares in the last quarter. DAVENPORT & Co LLC raised its position in shares of Markel Group by 2.4% in the 4th quarter. DAVENPORT & Co LLC now owns 209,999 shares of the insurance provider’s stock worth $452,365,000 after acquiring an additional 4,972 shares in the last quarter. Finally, Van Lanschot Kempen Investment Management N.V. lifted its stake in shares of Markel Group by 13.0% in the 4th quarter. Van Lanschot Kempen Investment Management N.V. now owns 204,861 shares of the insurance provider’s stock valued at $440,379,000 after purchasing an additional 23,631 shares during the period. Institutional investors own 77.12% of the company’s stock.

Insider Buying and Selling at Markel Group

In related news, Director Greta J. Harris sold 76 shares of the stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $1,847.31, for a total transaction of $140,395.56. Following the sale, the director directly owned 645 shares of the company’s stock, valued at approximately $1,191,514.95. This represents a 10.54% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Diane Leopold acquired 100 shares of Markel Group stock in a transaction on Wednesday, May 6th. The shares were purchased at an average price of $1,792.61 per share, with a total value of $179,261.00. Following the completion of the purchase, the director owned 2,190 shares in the company, valued at $3,925,815.90. This represents a 4.78% increase in their position. The SEC filing for this purchase provides additional information. 1.08% of the stock is owned by company insiders.

Markel Group Stock Performance

Markel Group stock opened at $1,978.80 on Friday. Markel Group Inc. has a twelve month low of $1,719.41 and a twelve month high of $2,207.59. The company has a quick ratio of 0.63, a current ratio of 0.63 and a debt-to-equity ratio of 0.24. The company has a market capitalization of $24.76 billion, a P/E ratio of 14.26 and a beta of 0.66. The stock’s 50 day moving average is $1,853.63 and its 200 day moving average is $1,971.77.

Markel Group (NYSE:MKL) last announced its quarterly earnings data on Tuesday, April 28th. The insurance provider reported ($18.90) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $26.38 by ($45.28). Markel Group had a net margin of 10.85% and a return on equity of 7.90%. The company had revenue of $3.55 billion for the quarter, compared to analysts’ expectations of $3.66 billion. On average, equities research analysts predict that Markel Group Inc. will post 113.55 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

MKL has been the topic of several research reports. Wall Street Zen lowered Markel Group from a “buy” rating to a “sell” rating in a research report on Saturday, May 2nd. Brean Capital began coverage on Markel Group in a research report on Tuesday, March 24th. They set a “neutral” rating and a $2,100.00 price objective for the company. Weiss Ratings cut shares of Markel Group from a “hold (c+)” rating to a “hold (c)” rating in a report on Thursday, June 11th. Truist Financial reduced their target price on shares of Markel Group from $2,100.00 to $1,950.00 and set a “hold” rating on the stock in a research report on Thursday, April 30th. Finally, Wolfe Research assumed coverage on shares of Markel Group in a research note on Wednesday. They issued an “underperform” rating for the company. Five equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $2,025.00.

About Markel Group

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.